SU1225574A1 - Method of treatment of psoriasis - Google Patents
Method of treatment of psoriasis Download PDFInfo
- Publication number
- SU1225574A1 SU1225574A1 SU833674811A SU3674811A SU1225574A1 SU 1225574 A1 SU1225574 A1 SU 1225574A1 SU 833674811 A SU833674811 A SU 833674811A SU 3674811 A SU3674811 A SU 3674811A SU 1225574 A1 SU1225574 A1 SU 1225574A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- treatment
- psoriasis
- days
- mannitol
- infusions
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
1one
Изобретение относитс к медицине и может быть использовано дл лечени псориаза .This invention relates to medicine and can be used to treat psoriasis.
Целью изобретени вл етс сокращение сроков лечени .The aim of the invention is to reduce the duration of treatment.
Способ осуществл етс следующим образом .The method is carried out as follows.
На фоне комплексного лечени поливитаминами , гемодезом, местной аппликацией лекаственных средств дополнительно ввод т 400- 500 мл 15%-ного раствора маннитола со скоростью 40-60 капель в минуту. На курс лечени провод т 3-5 инфузий.Against the background of complex treatment with multivitamins, hemodez, and local application of medicinal agents, an additional 400 to 500 ml of a 15% aqueous solution of mannitol are introduced at a rate of 40 to 60 drops per minute. 3-5 infusions are given per course of treatment.
Пример 1. Больной М., 24 лет, поступил в клинику с диагнозом распространенный псориаз в стадии прогрессирова- ни , экссудативна форма, псориатическа артралги . Больному назначены инфузий 15%-ного раствора маннитола в дозе 500 мл со скоростью 40 капель в минуту. Проведено три инфузий. На 7 день лечени исчезли экссудативные очаги на коже. Лечение продолжили введением витаминов В , BS, Example 1. Patient M., 24 years old, was admitted to the hospital with a diagnosis of advanced psoriasis in the progression stage, exudative form, psoriatic arthralgia. The patient was prescribed infusions of a 15% aqueous solution of mannitol at a dose of 500 ml at a rate of 40 drops per minute. Conducted three infusions. On the 7th day of treatment, the exudative foci on the skin disappeared. Treatment continued with the introduction of vitamins B, BS,
Редактор С. ПатрушеваEditor S. Patrushev
Составитель Ю. ЕмцовCompiled by Y. Yemtsov
Техред В.КадарКорректор А. ОбручарTehred V. KadarKorrektor A. Obruchar
Заказ 2017/4Тираж 660ПодписноеOrder 2017/4 Circulation 660Subscription
ВНИИПИ Государственного комитета СССРVNIIPI USSR State Committee
по делам изобретешш и открытий 113035, Москва, , Раушска наб,, д. 4/5on affairs of invention and discovery 113035, Moscow,, Raushsk nab ,, d. 4/5
Производственно-полиграфическое предпри тие, г. Ужгород, ул. Проектна , 4Production and printing company, Uzhgorod, st. Project, 4
25574 25574
внутримышечно, йжедисвио. Курс лечени продолжалс 10 дней. Сыпь полностью рассосалась. Выписан в удовлетворительном состо нии.intramuscularly, yzhedisvio. The course of treatment lasted 10 days. The rash has completely resolved. Discharged in satisfactory condition.
5five
Пример 2. Больной Ю., 27 лет, поступил с диагнозом распространенный псориаз в стадии прогрессировани , экссудативна форма, псориатическа артралги ,Example 2. Patient Y., 27 years old, was diagnosed with advanced psoriasis in the progression stage, exudative form, psoriatic arthralgia,
О Больному провели две инфуэии гемодеза по 400 мл внутривенно капельно со скоростью 60 капель в минуту через день, вводили витамины В , ВБ, внутримыщеч- но ежедневно в течение 10 дней, экстракт About the patient, two 400 ml hemodesic infusions were administered intravenously at a rate of 60 drops per minute every other day, injected with vitamins B, VB, intramuscularly daily for 10 days, the extract
(5 алоэ подкожно, ежедневно в течение 8 дней. Дополнительно назначено маннитол в дозе 400 мл через день 3 раза. Очаги поражени обрабатывались нафталановой мазью. Выписан на 38 день в состо нии полного клиничес20 кого выздоровлени .(5 aloe subcutaneously daily for 8 days. Additionally, mannitol was administered at a dose of 400 ml every other day 3 times. The lesions were treated with naphthalan ointment. Discharged on day 38 in a state of complete clinical recovery.
Предложенный способ лечени позвол ет сократить сроки лечени псориаза с 45-50 дней до 32-40 дней.The proposed method of treatment can reduce the time of treatment of psoriasis from 45-50 days to 32-40 days.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU833674811A SU1225574A1 (en) | 1983-12-15 | 1983-12-15 | Method of treatment of psoriasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU833674811A SU1225574A1 (en) | 1983-12-15 | 1983-12-15 | Method of treatment of psoriasis |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1225574A1 true SU1225574A1 (en) | 1986-04-23 |
Family
ID=21093690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU833674811A SU1225574A1 (en) | 1983-12-15 | 1983-12-15 | Method of treatment of psoriasis |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU1225574A1 (en) |
-
1983
- 1983-12-15 SU SU833674811A patent/SU1225574A1/en active
Non-Patent Citations (1)
Title |
---|
Вестник дерматологии, 1982, 9, 42-45. * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE322283T1 (en) | TRANSDERMAL USE OF SECRETIN TO TREAT AUTISM | |
GB1562871A (en) | Pharmaceutical composition | |
EP0263417A1 (en) | Use of hyaluronidase | |
ATE74006T1 (en) | MEDICATIONS WITH DESTRUCTIVE EFFECT ON MALIGNANT TUMORS, PROCESS FOR THEIR PRODUCTION AND PREPARATION FOR USE IN THE THERAPY OF CANCER PATIENTS. | |
KR910005858A (en) | Fatty acid therapy | |
Riordan et al. | Prolonged curarization in a patient with renal failure | |
SU1225574A1 (en) | Method of treatment of psoriasis | |
US5151425A (en) | Method of and composition for treating inflammation and the immunological response thereto | |
JPS60184011A (en) | Immuno-regulator | |
Johns | Cardiac arrest following induction with propanidid | |
DE2357074A1 (en) | VASCULAR-WIDENING AND SYMPATHOLYTIC MEDICINAL PRODUCT | |
SU1105202A1 (en) | Method of treatment of gastric ulcer and duodenal ulcer | |
SU1169655A1 (en) | Method of treatment of thrombolytic diseases of the artery of the extremities | |
US3885030A (en) | Medicine comprising lysine by-products | |
ĽAlessandro et al. | Safety of valproate in porphyria cutanea tarda | |
EP0347927A2 (en) | Use of 2-phenyl-1,2-benzisoselenazol-3(2H)-one (ebselen) in the preparation of medicaments for the treatment of malaria | |
SU1664326A1 (en) | Method for treating periodic acetonemic vomiting of children | |
SU1261662A1 (en) | Method of treatment of syndrome of anterior scalene muscle | |
SU1202591A1 (en) | Method of treatment of patients ill with allergic dermatosis | |
SU1171035A1 (en) | Method of curing syphilis | |
SU1697807A1 (en) | Method for treating candidiasis lesions of oral cavity and lip mucous membrane | |
SU1261670A1 (en) | Method of treatment of patients ill with chronic furunculosis | |
FR2431500A1 (en) | ADDED SALTS OF ERGOT DEXTROGYTIC ALKALOID ACIDS, THEIR PRODUCTION METHOD AND MEDICAMENTS CONTAINING THEM | |
SU1107867A1 (en) | Method of treatment of chronic gonorrhea | |
SU1243729A1 (en) | Method of treatment of neurodermite |